EUROFINS SCIENT Total Long Term Liabilities 2018-2023 | ERFSF
EUROFINS SCIENT total long term liabilities from 2018 to 2023. Total long term liabilities can be defined as the sum of all non-current liabilities.
| EUROFINS SCIENT Annual Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2023 | $3,928 |
| 2022 | $3,646 |
| 2021 | $3,312 |
| 2020 | $3,613 |
| 2019 | $3,745 |
| 2018 | $3,582 |
| 2017 | $2,146 |
| 2016 | $ |
| 2015 | $ |
| EUROFINS SCIENT Quarterly Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2022-12-31 | $3,646 |
| 2021-12-31 | $3,312 |
| 2021-06-30 | $3,365 |
| 2020-12-31 | $3,613 |
| 2020-06-30 | $3,516 |
| 2019-12-31 | $3,745 |
| 2019-06-30 | $3,305 |
| 2018-12-31 | $3,582 |
| 2018-06-30 | $2,288 |
| 2017-12-31 | $2,146 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.000B | $7.051B |
| Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.755B | 15.21 |
| Cencora (COR) | United States | $44.643B | 17.06 |
| ICON (ICLR) | Ireland | $24.824B | 22.31 |
| DiDi Global (DIDIY) | China | $19.247B | 0.00 |
| Avantor (AVTR) | United States | $18.832B | 28.56 |
| Natera (NTRA) | United States | $15.724B | 0.00 |
| Revvity (RVTY) | United States | $15.600B | 27.32 |
| Viatris (VTRS) | United States | $14.203B | 4.33 |
| CochLear (CHEOY) | Australia | $12.744B | 0.00 |
| Solventum (SOLV) | United States | $12.494B | 0.00 |
| Medpace Holdings (MEDP) | United States | $11.445B | 34.73 |
| Charles River Laboratories (CRL) | United States | $10.823B | 20.45 |
| Sonic Healthcare (SKHHY) | Australia | $8.820B | 0.00 |
| Doximity (DOCS) | United States | $7.543B | 47.80 |
| Bausch + Lomb (BLCO) | Canada | $7.041B | 30.30 |
| HealthEquity (HQY) | United States | $6.863B | 37.25 |
| PACS (PACS) | United States | $6.338B | 0.00 |
| Organon (OGN) | United States | $5.196B | 5.28 |
| Life Times (LTH) | United States | $4.995B | 41.75 |
| Sotera Health (SHC) | United States | $4.687B | 23.64 |
| Surgery Partners (SGRY) | United States | $4.212B | 46.66 |
| Concentras Parent (CON) | United States | $2.895B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $2.687B | 101.14 |
| BrightSpring Health Services (BTSG) | United States | $2.577B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.565B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.179B | 0.00 |
| Premier (PINC) | United States | $2.039B | 9.17 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.921B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.745B | 8.77 |
| Agilon Health (AGL) | United States | $1.592B | 0.00 |
| CareDx (CDNA) | United States | $1.576B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.572B | 0.00 |
| Progyny (PGNY) | United States | $1.486B | 26.13 |
| Establishment Labs Holdings (ESTA) | $1.228B | 0.00 | |
| GeneDx Holdings (WGS) | United States | $1.095B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.933B | 10.16 |
| QDM (QDMI) | Hong Kong, SAR China | $0.933B | 24.43 |
| Embecta (EMBC) | United States | $0.907B | 6.04 |
| InnovAge Holding (INNV) | United States | $0.827B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.551B | 0.00 |
| Sharecare (SHCR) | United States | $0.524B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.506B | 0.00 |
| Enhabit (EHAB) | United States | $0.414B | 35.83 |
| Sonida Senior Living (SNDA) | United States | $0.374B | 0.00 |
| DocGo (DCGO) | United States | $0.368B | 13.85 |
| Sera Prognostics (SERA) | United States | $0.260B | 0.00 |
| Biodesix (BDSX) | United States | $0.258B | 0.00 |
| LifeMD (LFMD) | United States | $0.227B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.208B | 0.00 |
| Beauty Health (SKIN) | United States | $0.190B | 0.00 |
| ModivCare (MODV) | United States | $0.181B | 5.75 |
| MultiPlan (MPLN) | United States | $0.137B | 0.00 |
| Nutex Health (NUTX) | United States | $0.128B | 0.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.083B | 0.00 |
| So-Young (SY) | China | $0.076B | 18.40 |
| NeueHealth (NEUE) | United States | $0.045B | 1.78 |
| Co-Diagnostics (CODX) | United States | $0.041B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.040B | 0.00 |
| OncoCyte (OCX) | United States | $0.040B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.028B | 0.00 |
| Oncology Institute (TOI) | United States | $0.022B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.021B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.011B | 0.00 |
| XWELL (XWEL) | United States | $0.010B | 0.00 |
| KindlyMD (KDLY) | $0.008B | 0.00 | |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |